How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Lung Cancer Trials

Select Clinical Trial

Protocol Number: ALCHEMIST

Protocol Title: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial

Eligibility: Men or women, ages 18 or older, diagnosed with Stage IIIA, II or large IB non-small cell lung cancer (NSCLC). 

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: MS200647_0005

Protocol Title:  A multicenter, double blind, randomized, controlled study of M7824 with concurrent chemoradiation followed by M7824 versus concurrent chemoradiation plus placebo followed by Durvalumab

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, stage III locally advanced, unresectable disease.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: LUNGMAP

Protocol Title: Master Protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (Lung-MAP Screening Study)

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, DISEASE MUST BE EITHER ADVANCED, stage IIIB or IV or recurrent.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: NRG-LU005

Protocol Title: LIMITED STAGE SMALL CELL LUNG CANCER (LS-SCLC): A PHASE II/III RANDOMIZED STUDY OF CHEMORADIATION VERSUS CHEMORADIATION PLUS ATEZOLIZUMAB

Eligibility: Men or women, ages 18 and older, diagnosed with limited stage small cell lung cancer.

Contact Information: (910) 715-2200

Specialties
Clara McLean House
Make a Donation
News & Events